David J. Drutz

4.0k total citations
82 papers, 3.1k citations indexed

About

David J. Drutz is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, David J. Drutz has authored 82 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 43 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in David J. Drutz's work include Fungal Infections and Studies (32 papers), Antifungal resistance and susceptibility (30 papers) and Nail Diseases and Treatments (19 papers). David J. Drutz is often cited by papers focused on Fungal Infections and Studies (32 papers), Antifungal resistance and susceptibility (30 papers) and Nail Diseases and Treatments (19 papers). David J. Drutz collaborates with scholars based in United States, Israel and Germany. David J. Drutz's co-authors include Stephen A. Klotz, John R. Graybill, M. Huppert, J. E. Zajic, Antonino Catanzaro, David Williams, M. Glenn Koenig, Bernard L. Powell, Philip C. Craven and David E. Rogers and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.

In The Last Decade

David J. Drutz

81 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Drutz United States 36 1.7k 1.5k 483 302 243 82 3.1k
J. A. A. Hoogkamp‐Korstanje Netherlands 34 1.5k 0.9× 1.2k 0.8× 413 0.9× 198 0.7× 183 0.8× 111 3.4k
J. Burnie United Kingdom 36 2.2k 1.3× 1.5k 1.0× 803 1.7× 335 1.1× 125 0.5× 107 3.4k
Roy T. Steigbigel United States 36 2.2k 1.3× 1.8k 1.1× 621 1.3× 525 1.7× 263 1.1× 75 4.6k
Robert H.K. Eng United States 33 1.5k 0.9× 1.5k 1.0× 510 1.1× 152 0.5× 254 1.0× 116 3.4k
R. R. Marples United Kingdom 35 1.7k 1.0× 893 0.6× 725 1.5× 234 0.8× 212 0.9× 97 4.1k
Hironobu Koga Japan 28 916 0.5× 1.1k 0.7× 433 0.9× 176 0.6× 254 1.0× 127 2.3k
Takayoshi Tashiro Japan 32 1.5k 0.9× 1.5k 1.0× 439 0.9× 216 0.7× 220 0.9× 141 2.7k
Ronald G. Washburn United States 20 1.6k 0.9× 1.1k 0.7× 226 0.5× 196 0.6× 114 0.5× 41 2.3k
F. Jacobs Belgium 26 1.1k 0.6× 1.2k 0.8× 426 0.9× 209 0.7× 172 0.7× 62 2.5k
Thomas M. Kerkering United States 25 2.0k 1.2× 1.9k 1.2× 207 0.4× 136 0.5× 113 0.5× 56 2.9k

Countries citing papers authored by David J. Drutz

Since Specialization
Citations

This map shows the geographic impact of David J. Drutz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Drutz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Drutz more than expected).

Fields of papers citing papers by David J. Drutz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Drutz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Drutz. The network helps show where David J. Drutz may publish in the future.

Co-authorship network of co-authors of David J. Drutz

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Drutz. A scholar is included among the top collaborators of David J. Drutz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Drutz. David J. Drutz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jacobs, P, David J. Drutz, G. Cauwenbergh, et al.. (1992). Progress in antifungal chemotherapy. Medical Mycology. 30(s1). 197–199. 5 indexed citations
2.
Medoff, Gerald, William E. Dismukes, Demosthenes Pappagianis, et al.. (1992). Evaluation of New Antifungal Drugs for the Treatment of Systemic Fungal Infections. Clinical Infectious Diseases. 15(Supplement_1). S274–S281. 19 indexed citations
3.
Rosenberg, Martin, et al.. (1990). Soluble recombinant CD4 — A potential therapeutic agent for HIV infection. Biotherapy. 2(2). 107–118. 2 indexed citations
4.
Brooks, David P., David J. Drutz, & R R Ruffolo. (1990). Prevention and complete reversal of cyclosporine A-induced renal vasoconstriction and nephrotoxicity in the rat by fenoldopam.. Journal of Pharmacology and Experimental Therapeutics. 254(2). 375–379. 19 indexed citations
5.
Drutz, David J., et al.. (1989). Divergent Patterns of Pulmonary Blastomycosis Induced by Conidia and Yeasts in Athymic and Euthymic Mice. American Review of Respiratory Disease. 140(1). 118–124. 8 indexed citations
6.
Drutz, David J.. (1987). In Vitro Antifungal Susceptibility Testing and Measurement of Levels of Antifungal Agents in Body Fluids. Clinical Infectious Diseases. 9(2). 392–397. 36 indexed citations
7.
Drutz, David J.. (1987). Controversies in the Diagnosis and Management of Infectious Diseases. Session V: Fungal Infections. Summary and Discussion. Clinical Infectious Diseases. 9(2). 417–420. 3 indexed citations
8.
Drutz, David J., et al.. (1986). Influence of Fungal Surface Components on the Interaction of Coccidioides immitis with Polymorphonuclear Neutrophils. The Journal of Infectious Diseases. 153(5). 933–943. 39 indexed citations
9.
Jorgensen, J. H., et al.. (1983). Activity of aztreonam and new beta-lactam antibiotics against penicillinase-producing Neisseria gonorrhoeae. Current Therapeutic Research. 34(6). 955–959. 4 indexed citations
10.
Jorgensen, J. H., et al.. (1983). Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrobial Agents and Chemotherapy. 24(2). 282–286. 43 indexed citations
11.
Robledo, Mary Ann, et al.. (1982). Host Defense Against Experimental Paracoccidioidomycosis 1- 3. American Review of Respiratory Disease. 125(5). 563–567. 35 indexed citations
12.
Drutz, David J., M. Huppert, Steven Sun, & William McGuire. (1981). Human sex hormones stimulate the growth and maturation of Coccidioides immitis. Infection and Immunity. 32(2). 897–907. 78 indexed citations
13.
Drutz, David J., Martin J. Cline, & L Lévy. (1974). Leukocyte antimicrobial function in patients with leprosy.. Journal of Clinical Investigation. 53(2). 380–386. 26 indexed citations
14.
Drutz, David J.. (1973). Antibiotic Therapy in Compromised Hosts. PubMed Central. 119(1). 49. 3 indexed citations
15.
Drutz, David J. & Robert Gutman. (1973). Renal manifestations of leprosy: Glomerulonephritis, a complication of erythema nodosum leprosum. American Journal of Tropical Medicine and Hygiene. 22(4). 496–502. 40 indexed citations
16.
Tai, T Y, et al.. (1970). Application of new method of amphotericin B administration to cyrptococcal meningitis.. PubMed. 69(5). 241–2. 1 indexed citations
17.
Gutman, Robert, David J. Drutz, George E. Whalen, & R. H. Watten. (1969). DOUBLE BLIND FLUID THERAPY EVALUATION IN PEDIATRIC CHOLERA. PEDIATRICS. 44(6). 922–931. 20 indexed citations
18.
Drutz, David J., M. Glenn Koenig, & David E. Rogers. (1967). FURTHER OBSERVATIONS ON THE MECHANISM OF RETICULOENDOTHELIAL BLOCKADE. The Journal of Experimental Medicine. 126(6). 1087–1098. 9 indexed citations
19.
Drutz, David J., Anderson Spickard, & M. Glenn Koenig. (1967). New approach to therapy with amphotericin B.. 202–207. 1 indexed citations
20.
Drutz, David J., et al.. (1966). Bacterial Interference in the Therapy of Recurrent Staphylococcal Infections. RePub (Erasmus University Rotterdam). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026